Ropivicaine is one of 66 small molecule programs targeting Shoulder Arthroplasty. It is currently in Phase 3.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
84 competitors in Cesarean Section
Ropivicaine
Fentanyl-Morphine
Ondansetron, Dexamethasone
Acetaminophen/ibuprofen
Sebacoyl Dinalbuphine Ester
Morphine - .
Dynastat
Proamatine
Duragesic
Versed
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Sources
Details